Americans With ALS Look to Canada for Promising Drug the U.S. Hasn’t Approved
Canada approved
Amylyx Pharmaceuticals Inc.’s
new drug for amyotrophic lateral sclerosis last week. Now some U.S. patients with the fatal neurodegenerative disorder—also known as Lou Gehrig’s disease—are…